FdaApplication
ANDA 212786
Identifiers
- fda_app_no: ANDA212786
Properties
| Property | Value |
|---|---|
| applicant_name | LAURUS LABS LTD |
| application_type | ANDA |
| approval_date | 2020-05-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG;300MG;300MG | TABLET;ORAL |
1 product